08/01/2025
🌟 Repost from .talk.menopause via Gabriella Espinosa 🌟
“Menopause just made history at the FDA — and the message was loud and clear: women deserve evidence-based care, not fear-based medicine.”
i
🔑 Five Key Takeaways from the FDA Experts Panel:
1. Low-dose vaginal estrogen is safe, effective, and underutilized — crucial for treating Genitourinary Syndrome of Menopause without systemic risks.
2. Systemic estrogen therapy, when started within 10 years of menopause or before age 60, still shows clear benefits with far lower risk than commonly believed.
3. Testosterone therapy for women can be life-changing — improving mood, libido, muscle mass, and metabolic resilience.
4. Hormone therapy supports bone health — reducing fracture risk and preserving skeletal strength long-term.
5. Experts from menopause, urology, neuro, internal medicine united in calling for updated, nuanced prescribing guidance, not fear promotion.
At Rosie, we’re ahead of the curve — integrating the latest menopause science into your care. That means personalized protocols for vaginal estrogen, bioidentical hormone therapy, bone density support, and tools like the SECA body composition analyzer to monitor visceral fat and muscle mass over time.
Because menopause isn’t the end of vitality — it’s a shift into evidence-based empowerment.
💬 Curious how these shifts could impact your hormone plan? Let’s chat.
❤️
